Miami Transplant Institute
Miami Transplant Institute is a non-profit transplant center founded in 1970 and operated jointly by Jackson Health System and UHealth, performing 700+ organ transplant procedures annually across all organ types for adult and pediatric patients, serving as the nation's #1 kidney transplant program by cumulative volume.
- Company typePrivate
- Founded1970
- HeadquartersMiami, United States
- Headcount11–50
- GTM typeB2C
- OfferingServices
What Miami Transplant Institute does
Miami Transplant Institute (MTI) is a comprehensive, non-profit transplant center founded in 1970 as a collaboration between Jackson Health System (a public, government-affiliated health system) and UHealth – University of Miami Health System. It operates one of the largest and most comprehensive organ transplant programs in the United States, performing 700+ procedures annually across all major organ types — kidney, liver, heart, lung, pancreas, intestinal, and multivisceral — for both adult and pediatric patients. MTI is the only center in Florida performing all organ transplant types, ranks #1 in the U.S. for cumulative kidney transplant volume (approximately 10,000 since 1988), and is consistently a top-3 national program for kidney, kidney-pancreas, liver, intestinal, and multivisceral transplants. Its service footprint includes a 69-bed main campus at Jackson Memorial Medical Center, outpatient diagnostic centers in Plantation and Pompano Beach, and pediatric clinics in Orlando and Gainesville, with patients referred from across the U.S. and abroad.
The institute's core technology portfolio includes robotic-assisted living kidney transplantation (the only program of its kind in Florida), advanced ECMO life support (60+ procedures annually with ELSO Silver Level recognition), intestinal and multivisceral transplantation (15-20% of all U.S. intestinal transplants), and transplant oncology in collaboration with Sylvester Comprehensive Cancer Center. Revenue is generated through professional services reimbursed by health insurance, Medicare, and Medicaid on a volume-based model across transplant surgeries, living donor programs, ECMO services, and intestinal rehabilitation, supplemented by philanthropy through Jackson Health Foundation. MTI serves patients with end-stage organ failure, including those turned down at other centers, and accepts complex, high-risk cases through a referral-driven go-to-market model that includes a national physician referral network, direct patient intake, and a virtual second opinion program. The institute also offers the only paired kidney exchange program in South Florida, including Florida's first three-way and four-way paired kidney exchanges.
Miami Transplant Institute firmographics
Firmographics- Name
- Miami Transplant Institute
- Legal name
- Jackson Health System
- Website
- https://transplant.jacksonhealth.org
- Company type
- Private
- Founded year
- 1970
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Miami Transplant Institute is a non-profit transplant center founded in 1970 and operated jointly by Jackson Health System and UHealth, performing 700+ organ transplant procedures annually across all organ types for adult and pediatric patients, serving as the nation's #1 kidney transplant program by cumulative volume.
- Ownership category
- akta.pro rank
Miami Transplant Institute industry classification
Industry- Product category
- Organ Transplant Services
- NAICS
- Blood and Organ Banks (621991)
- akta.pro primary industry
- Transplant Specialty Hospitals (HLAFAHAE)
- akta.pro secondary industries
- Renal Transplant Medicine (Pre/Post-Transplant Care) (HLAKAHAD), Transplant Hepatology (HLAKAEAK), Transplant Urology (HLAKAOAJ), Blood, Organ & Tissue Donation Organizations (BPAGACAJ)
Keywords
Where Miami Transplant Institute is headquartered
LocationHeadquarters
- HQ city
- Miami
- HQ country
- United States
- HQ region
- North America
Offices6 records
Markets served
Miami Transplant Institute business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Transplant Surgery Services: Revenue generated from performing organ transplant surgeries including kidney, liver, heart, lung, pancreas, intestinal, and multivisceral transplants. Services covered by health insurance, Medicare, and Medicaid. Volume-based reimbursement model based on procedure complexity.
- Living Donor Program Services: Living kidney donor transplants and paired kidney exchange program services. Costs covered by Kidney Acquisition Fund and/or recipient's insurance.
- ECMO and Life Support Services: Temporary life support services for failing hearts and lungs through ECMO procedures.
- Intestinal Rehabilitation: Non-transplant surgical and medical care for digestive tract disorders. Treatment includes nutritional, medical, and surgical interventions.
- Philanthropy and Donations: Donations through Jackson Health Foundation to fund research, academic achievement, and innovative treatments. Major gift categories include Endowed Chair ($2,000,000), Endowed Professorship ($1,500,000), Endowed Post Doctoral Fellowship ($500,000), Research Fund ($250,000+), and Laboratory naming ($100,000+).
Go-to-market motion2 records
Distribution channels5 records
Marketing channels7 records
Miami Transplant Institute product offering
Product offeringCore offering
Miami Transplant Institute is a comprehensive transplant center providing life-saving organ transplantation for adults and children, including kidney, kidney-pancreas, liver, intestinal, multivisceral, heart, and lung transplants, plus ventricular assist device (VAD) implantation, ECMO life support, and intestinal rehabilitation. It also runs living kidney donor and paired kidney exchange programs, Florida's only fully robotic living kidney transplant service, and a transplant oncology program for liver cancer patients.
Product overview
Miami Transplant Institute (MTI) is a comprehensive transplant center offering life-saving organ transplantation and rehabilitation services for adults and children. The institution operates as a single unified healthcare delivery system backed by Jackson Health System and the University of Miami Miller School of Medicine. Its portfolio includes eight core transplant programs: Kidney (with Living Donor and Paired Exchange), Kidney-Pancreas/Pancreas, Liver (adult and pediatric), Intestinal Rehabilitation, Intestinal/Multivisceral, Heart/VAD, Lung (adult and pediatric), and ECMO. These are supplemented by innovative services such as Robotic Living Kidney Transplant, Transplant Oncology, and a Second Opinion Program. The institute also provides an Adult Solid Organ Transplant Support Group. MTI is the only center in Florida performing all types of organ transplants and is ranked among the top five transplant centers nationally for combined volume.
Differentiator
Problem solved
Functional benefit
Products and services
- Kidney Transplant Program Adult kidney transplant surgery for end-stage kidney disease, including the Living Donor Kidney Program, Paired Kidney Exchange Program, and APOLLO Kidney Study participation. Has performed approximately 10,000 kidney transplants since 1988 and 400+ transplants annually.
- Pediatric Kidney Transplant Program National leader in pediatric kidney transplantation for children facing end-stage kidney disease, integrated with Holtz Children's Hospital.
- Kidney-Pancreas and Pancreas Transplant Program Combined kidney-pancreas transplants for patients with diabetes-related kidney failure, as well as pancreas-after-kidney and pancreas-alone transplants. Program ranked #2 in the U.S. for kidney-pancreas volume.
- Liver Transplant Program Adult and pediatric liver transplantation including deceased-donor, living donor, and split liver transplants. Performs 150+ liver transplants annually with over 5,000 performed since 1988.
- Pediatric Liver Transplant Program Pediatric liver transplantation for children with liver disease, integrated with Holtz Children's Hospital, performing 10+ pediatric liver transplants annually.
- Intestinal Rehabilitation Program Multidisciplinary program treating digestive tract disorders without transplants, helping patients resume eating by mouth and reduce or eliminate parenteral nutrition (IV feeding). Has treated over 100 patients.
- Intestinal and Multivisceral Transplant Program Small intestine, modified multivisceral, and full multivisceral transplants for patients with intestinal failure. Performs 15-20% of all U.S. intestinal transplant surgeries and is the only intestinal program in the southern U.S.
- Heart Transplant and Ventricular Assist Device (VAD) Program Adult and pediatric heart transplants and VAD implantation for heart failure. Has performed over 1,000 heart transplants and VAD procedures since 1986, with 50-60 performed annually. Also performs complex multi-organ transplants including heart-liver and heart-lung-liver procedures.
- Lung Transplant Program Single-lung, double-lung, and heart-lung transplants for adults and children with severe lung disease. Florida's most experienced lung surgery team, established in 2022 as part of the Lung Center at Jackson Health System.
- Pediatric Lung Transplant Program Pediatric lung transplantation for children with severe lung disease, one of the leading pediatric lung transplant centers in the nation.
- Extracorporeal Membrane Oxygenation (ECMO) Program Temporary mechanical support for failing hearts and lungs in children and adults. Performs 60+ ECMO procedures annually with survival rates exceeding ELSO registry averages. ECMO Silver Level ELSO Award recipient.
- Living Donor Kidney Program Living kidney donation program, the largest in Florida and fastest-growing in the Southeast. Allows recipients to receive better-matched kidneys from living donors including parents, relatives, friends, or strangers.
- Paired Kidney Exchange Program Kidney donor matching program that pairs incompatible donors with compatible recipients. The only initiative of its kind in South Florida. Has performed Florida's first three-way and four-way paired kidney exchanges.
- Robotic Living Kidney Transplant Florida's only fully robotic living kidney transplant program for donors and recipients. Benefits include less pain, fewer complications, reduced hospital stay, shorter recovery time, higher precision surgery, and minimally invasive approach.
- Transplant Oncology Program Liver transplantation for cancer patients, treating cholangiocarcinoma, hepatocellular carcinoma, neuroendocrine tumors, and non-resectable metastatic colon cancer to the liver. Offered through collaboration between Jackson Health System and Sylvester Comprehensive Cancer Center.
- Second Opinion Program Virtual evaluation program for patients who have been turned down at other transplant centers. Provides multidisciplinary team assessment, access to advanced techniques, and among the shortest transplant wait times in the country. Includes a 72-hour callback promise.
Quantifiable outcome
- 700+ transplant procedures annually for patients from throughout the U.S. and abroad
- +7 more outcomes
Companies that use Miami Transplant Institute
Customer profileNamed customers7 records
Segments5 records
Ideal customer profiles5 records
Miami Transplant Institute technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Miami Transplant Institute partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered minor, core and strategic.
- Goodwill Industries of South FloridaminorGoodwill Industries of South Florida manufactures the custom hospital gowns designed by René Ruiz for MTI transplant patients. Over 4,000 gowns delivered. Goodwill's mission provides hope and job opportunities to people with disabilities.
- René Ruiz (RENÉ BY RR)minorMiami fashion designer who created custom hospital gowns for transplant patients. Designed gowns with snaps and slits for easier medical access, with pockets. First patients received gowns June 3, 2021.
- Jackson Health SystemcoreJackson Health System is the public hospital network partner in the Miami Transplant Institute collaboration. Provides the hospital infrastructure, beds (69 beds across two specialized floors), and emergency/acute care facilities including Jackson Memorial Medical Center campus.
- UHealth – University of Miami Health SystemcoreUHealth is the academic medical center partner providing physician expertise, research capabilities, and affiliation with University of Miami Miller School of Medicine. Keeps doctors on leading-edge of transplant medicine.
- Holtz Children's HospitalcoreHoltz Children's Hospital, part of Jackson Health System, provides pediatric transplant services. Located on Jackson Memorial Medical Center campus. Consistently ranked among top children's hospitals by U.S. News & World Report.
- Sylvester Comprehensive Cancer CenterstrategicJoint collaboration for transplant oncology treating liver cancer patients. Part of UHealth. Allows MTI to offer liver transplantation to cancer patients including those with cholangiocarcinoma, hepatocellular carcinoma, and neuroendocrine tumors.
- Extracorporeal Life Support Organization (ELSO)minorWorldwide data registry monitoring quality standards for ECMO centers. MTI is a member and active participant. Their survival-to-hospital discharge rates exceed the average reported from all centers in the ELSO registry.
- APOLLO Consortium (APOL1 Long-term Kidney Transplantation Outcomes)strategicNational observational study testing kidney donors and recipients for APOL1 gene variants. MTI recognized as a clinical participating center. Study aims to improve outcomes after kidney donation and transplantation.
Scale indicators20 records
Recent moves9 records
Expansion highlights6 records
Miami Transplant Institute competitors and assessment
Company assessmentDirect peers
- Stanford Health Care Transplant Program: West Coast academic multi-organ transplant program with strong kidney, liver, heart, and lung volumes and innovation leadership (including robotic transplant techniques). Comparable to MTI on academic integration and innovation focus.
- Massachusetts General Hospital Transplant Center: Northeast academic multi-organ transplant program with nationally ranked kidney, liver, heart, and lung transplant programs. Comparable to MTI on case complexity, academic affiliation, and national referral positioning.
- Mayo Clinic Transplant Center: Top-tier U.S. multi-organ transplant program (kidney, liver, heart, lung, pancreas) with academic medical center backing and a national/international referral base — directly comparable to MTI's positioning, scale, and case-complexity profile.
- Cleveland Clinic Transplant Center: One of the largest multi-organ transplant programs in the U.S., offering heart, lung, liver, kidney, pancreas, and intestinal transplants with similar national-referral, high-complexity positioning. Directly comparable to MTI across nearly every organ program.
- UCLA Health Transplant Program: High-volume West Coast multi-organ transplant program with kidney, liver, heart, and lung capabilities and academic medical center backing. Directly comparable to MTI on organ-type breadth and academic-affiliated scale.
- Johns Hopkins Comprehensive Transplant Center: Academic multi-organ transplant program with national/international referral reach and leadership in complex kidney, liver, and intestinal cases. Directly comparable peer for MTI's complex-case and academic-center profile.
- Cedars-Sinai Comprehensive Transplant Center: High-volume multi-organ transplant program with leading kidney and liver transplant volumes, complex case acceptance, and a national referral footprint — directly comparable to MTI's scale and operating model.
- UCSF Health Transplant Program: Academic multi-organ transplant program with national leadership in kidney, liver, heart, and lung transplants, including complex and living-donor cases. Directly comparable peer for MTI's high-acuity, high-volume academic center profile.
- NYU Langone Transplant Institute: Top-tier multi-organ transplant program with strong kidney, liver, and heart transplant volumes and a national referral network. Comparable to MTI on scale, academic backing, and complex-case positioning.
- UPMC (University of Pittsburgh Medical Center) Transplant Services: Historically the largest U.S. transplant program, with deep expertise across all solid organs, including the historically pioneering intestinal transplant program. Direct peer to MTI on volume, complexity, and academic-center integration.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat6 records
Key risks7 records
Key highlights7 records
Customer concentration
Miami Transplant Institute social profiles
Digital presenceMiami Transplant Institute compliance and trust
Trust signalCompliance1 record
Miami Transplant Institute financial estimates
Financial estimateRevenue estimate
Valuation estimate
Miami Transplant Institute leadership team
Management profileNumber of profiles
Profiles1 record
Miami Transplant Institute funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Miami Transplant Institute M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Miami Transplant Institute
What does Miami Transplant Institute do?
Miami Transplant Institute is a comprehensive transplant center providing life-saving organ transplantation for adults and children, including kidney, kidney-pancreas, liver, intestinal, multivisceral, heart, and lung transplants, plus ventricular assist device (VAD) implantation, ECMO life support, and intestinal rehabilitation. It also runs living kidney donor and paired kidney exchange programs, Florida's only fully robotic living kidney transplant service, and a transplant oncology program for liver cancer patients.
Is Miami Transplant Institute a public or private company?
Miami Transplant Institute is a private company. It is classified as state government owned and is currently operating.
When was Miami Transplant Institute founded?
Miami Transplant Institute was founded in 1970. It employs 11 to 50 people.
Where is Miami Transplant Institute based?
Miami Transplant Institute is headquartered in Miami, United States, in the North America region.
How does Miami Transplant Institute make money?
Five revenue lines are on record. Transplant Surgery Services are the primary driver. The others are living Donor Program Services, ECMO and Life Support Services, intestinal Rehabilitation and philanthropy and Donations.
Who are Miami Transplant Institute's main competitors?
Direct peers on record are Stanford Health Care Transplant Program, Massachusetts General Hospital Transplant Center, Mayo Clinic Transplant Center, Cleveland Clinic Transplant Center, UCLA Health Transplant Program, Johns Hopkins Comprehensive Transplant Center, Cedars-Sinai Comprehensive Transplant Center, UCSF Health Transplant Program, NYU Langone Transplant Institute and UPMC (University of Pittsburgh Medical Center) Transplant Services.
Does Miami Transplant Institute have an API?
No public API is recorded for Miami Transplant Institute.
What industry is Miami Transplant Institute in?
Miami Transplant Institute's product category is Organ Transplant Services. Its primary akta.pro industry code is HLAFAHAE, Transplant Specialty Hospitals, with a secondary code of HLAKAHAD, Renal Transplant Medicine (Pre/Post-Transplant Care). Its NAICS code is 621991.